288
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Identifying predictive factors for admitting patients with severe pre-eclampsia to intensive care unit

, , , , , , , & show all
Pages 3175-3181 | Received 25 Mar 2020, Accepted 20 Aug 2020, Published online: 08 Sep 2020

References

  • Say L, Chou D, Gemmill A, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323–e333.
  • Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33(3):130–137.
  • Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365(9461):785–799.
  • Brown MA, Lindheimer MD, de Swiet M, et al. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy. 2001;20:IX–XIV.
  • Dadelszen von P, Ornstein MP, Bull SB, et al. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet. 2000;355(9198):87–92.
  • Barton JR, Sibai BM. Prediction and prevention of recurrent preeclampsia. Obstet Gynecol. 2008;112(2 Pt 1):359–372.
  • Lecarpentier E, Gris JC, Cochery-Nouvellon E, et al. Urinary placental growth factor for prediction of placental adverse outcomes in high-risk pregnancies. Obstet Gynecol. 2019;134(6):1326–1332.
  • Bretelle F, Ledu R, Haumonté J-B, et al. Can we foretell preeclampsia?. Ann Fr Anesth Reanim. 2010;29(3):e19–e24.
  • Poon LC, Nicolaides KH. Early prediction of preeclampsia. Obstet Gynecol Int. 2014;2014:297397
  • Roberge S, Bujold E, Nicolaides KH. Meta-analysis on the effect of aspirin use for prevention of preeclampsia on placental abruption and antepartum hemorrhage. Am J Obstet Gynecol. 2018;218(5):483–489.
  • Loussert L, Vidal F, Parant O, et al. Aspirin for prevention of preeclampsia and fetal growth restriction. Prenat Diagn. 2020;40(5):519–552.
  • Rana S, Lemoine E, Granger JP, et al. Preeclampsia: pathophysiology, challenges, and perspectives. Circ Res. 2019;124(7):1094–1112.
  • Guerby P, Vidal F, Garoby-Salom S, et al. Oxidative stress and preeclampsia: A review. Gynecol Obstet Fertil. 2015;43(11):751–756.
  • Many A, Kuperminc MJ, Pausner D, et al. Treatment of severe preeclampsia remote from term: A clinical dilemma. Obstet Gynecol Surv. 1999;54(11):723–727.
  • Friedman SA, Schiff E, Kao L, et al. Neonatal outcome after preterm delivery for preeclampsia. Am J Obstet Gynecol. 1995;172(6):1785–1788–discussion1788–92.
  • Magee LA, Pels A, Helewa M, et al. Dadelszen von P, SOGC Hypertension Guideline Committee. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: Executive summary. J Obstet Gynaecol Can. 2014;36(7):575–576.
  • Atallah AN, Hofmeyr GJ, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2000;2000(3):CD001059.
  • Altman D, Carroli G, Duley L, et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet. 2002;359(9321):1877–1890.
  • Dekker G, Sibai B. Primary, secondary, and tertiary prevention of pre-eclampsia. Lancet. 2001;357(9251):209–215.
  • Walker JJ. Pre-eclampsia. Lancet. 2000;356(9237):1260–1265.
  • de Souza Urbanetto J, Travi Canabarro S, Prado Lima Figueiredo AE, et al. Correlation between the TISS-28 and NEMS indicators in an intensive care unit. Int J Nurs Pract. 2014;20(4):375–381.
  • Miranda DR, de Rijk A, Schaufeli W. Simplified therapeutic intervention scoring system: the TISS-28 items–results from a multicenter study. Crit Care Med. 1996;24(1):64–73.
  • Walker JJ. Care of the patient with severe pregnancy induced hypertension. Eur J Obstet Gynecol Reprod Biol. 1996;65(1):127–135.
  • Deleu F, Deneux-Tharaux C, Chiesa-Dubruille C, et al. EPIMOMS study group (see Appendix). A population-based analysis of French transfusion practices for women experiencing severe postpartum hemorrhage. Int J Obstet Anesth. 2019;42:11–19.
  • Korb D, Goffinet F, Seco A, et al. Risk of severe maternal morbidity associated with cesarean delivery and the role of maternal age: a population-based propensity score analysis. CMAJ. 2019;191(13):E352–E360.
  • Dekker GA, Sibai BM. Early detection of preeclampsia. Am J Obstet Gynecol. 1991;165(1):160–172.
  • Dadelszen von P, Payne B, Li J, et al. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet. 2011;377(9761):219–227.
  • Voto LS, Illia R, Darbon-Grosso HA, et al. Uric acid levels: a useful index of the severity of preeclampsia and perinatal prognosis. J Perinat Med. 1988;16(2):123–126.
  • Webster K, Fishburn S, Maresh M, et al. Diagnosis and management of hypertension in pregnancy: summary of updated NICE guidance. BMJ. 2019;366:l5119.
  • ACOG Practice Bulletin No. 202: Gestational hypertension and preeclampsia. Obstet Gynecol. 2019;133(1):e1–e25.
  • Sibai BM. What to expect from expectant management in severe preeclampsia at <34 weeks gestation: pregnancy outcomes in developed vs developing countries. Am J Obstet Gynecol. 2013;209(5):400–401.
  • Winer N, Branger B. Collége national des gynécologues et obstétriciens, Société française de médecine périnatale, Société française de néonatalogie, Société française de anesthésie et de réanimation. [Management of preeclampsia in a perinatal network]. Annales Françaises D'Anesthésie et de Réanimation. 2010;29(4):e47–e50.
  • Diemunsch P, Langer B, Noll E, Société française de anesthésie et de reanimation [Intrahospital management of women with preeclampsia]. Ann Fr Anesth Reanim. 2010;29(4):e51–e58.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.